Arja de Goede-Bolder

1.7k citations

22 papers · 1.2k indexed · h-index 19

Hematology top 2%
Neurology top 2%
Epidemiology top 10%
Genetics top 5%
Surgery

Co-authors: Johanna G. van der Bom Henriëtte A. Moll E. P. Mauser‐Bunschoten Lianne C. Krab Ype Elgersma Marjolein Peters Cees Smit Marjon H. Cnossen
Topics: Neurofibromatosis and Schwannoma Cases (9 papers)Platelet Disorders and Treatments (6 papers)Hemophilia Treatment and Research (5 papers)
Cited by: Hematology Neurology Genetics
Journals: Blood PEDIATRICS The Journal of Pediatrics
Partner nations: Netherlands United States Canada

In The Last Decade

Arja de Goede-Bolder

22 papers receiving 1.2k citations

Peers

Countries citing papers authored by Arja de Goede-Bolder

Since Specialization

Citations

This map shows the geographic impact of Arja de Goede-Bolder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arja de Goede-Bolder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arja de Goede-Bolder more than expected).

Fields of papers citing papers by Arja de Goede-Bolder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arja de Goede-Bolder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arja de Goede-Bolder. The network helps show where Arja de Goede-Bolder may publish in the future.

Co-authorship network of co-authors of Arja de Goede-Bolder

This figure shows the co-authorship network connecting the top 25 collaborators of Arja de Goede-Bolder. A scholar is included among the top collaborators of Arja de Goede-Bolder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arja de Goede-Bolder. Arja de Goede-Bolder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The group medical appointment (GMA) in haemophilia and von Willebrand’s disease: a new development in outpatient paediatric care 2012 ·Haemophilia ·(unknown),Arnout de Bruin,M. F. Scholten,Marieke Joosten,(unknown),Auke Beishuizen,Arja de Goede-Bolder,Marjon H. Cnossen	4
2	Determinants of bleeding phenotype in adult patients with moderate or severe von Willebrand disease 2012 ·Thrombosis and Haemostasis ·Eva M. de Wee,Yvonne Sanders,Eveline P. Mauser‐Bunschoten,Johanna G. van der Bom,(unknown),Jeroen Eikenboom,Arja de Goede-Bolder,Britta A. P. Laros‐van Gorkom,Karina Meijer,Karly Hamulyák,Marten R. Nijziel,Karin Fijnvandraat,Frank W.G. Leebeek,(unknown)	85
3	Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease 2011 ·Thrombosis and Haemostasis ·Eva M. de Wee,H.M. Knol,Evelien P. Mauser‐Bunschoten,Johanna G. van der Bom,Jeroen Eikenboom,Karin Fijnvandraat,Arja de Goede-Bolder,(unknown),Paula F. Ypma,Sonja Zweegman,Karina Meijer,Frank W.G. Leebeek,(unknown)	62
4	Health‐related quality of life among adult patients with moderate and severe von Willebrand disease 2010 ·Journal of Thrombosis and Haemostasis ·Eva M. de Wee,E. P. Mauser‐Bunschoten,Johanna G. van der Bom,(unknown),Jeroen Eikenboom,Karin Fijnvandraat,Arja de Goede-Bolder,Britta A. P. Laros‐van Gorkom,Karina Meijer,Hein Raat,Frank W.G. Leebeek	81
5	Health-related quality of life in preschool children in five health conditions 2010 ·Quality of Life Research ·(unknown),Rianne Oostenbrink,Jeanne M. Landgraf,Edwin Rietveld,Arja de Goede-Bolder,Eduard F. van Beeck,(unknown),Hein Raat,Henriëtte A. Moll	30
6	Motor Learning in Children with Neurofibromatosis Type I 2010 ·The Cerebellum ·Lianne C. Krab,Arja de Goede-Bolder,Femke K. Aarsen,Henriëtte A. Moll,Chris I. De Zeeuw,Ype Elgersma,Jos N. van der Geest	31
7	Impact of von Willebrand disease on health‐related quality of life in a pediatric population 2010 ·Journal of Thrombosis and Haemostasis ·Eva M. de Wee,Karin Fijnvandraat,Arja de Goede-Bolder,E. P. Mauser‐Bunschoten,Jeroen Eikenboom,Paul Brons,Frans J. Smiers,R. Y. J. Tamminga,Rianne Oostenbrink,Hein Raat,Johanna G. van der Bom,Frank W.G. Leebeek	32
8	Physical fitness in children with haemophilia and the effect of overweight 2008 ·Haemophilia ·(unknown),R. H. H. Engelbert,Frank R. van Genderen,(unknown),Arja de Goede-Bolder,Annelies Hartman	47
9	Quantitative Differentiation Between Healthy and Disordered Brain Matter in Patients with Neurofibromatosis Type I Using Diffusion Tensor Imaging 2008 ·American Journal of Neuroradiology ·(unknown),Lianne C. Krab,Henriëtte A. Moll,Arja de Goede-Bolder,Saskia M.F. Pluijm,Coriene E. Catsman‐Berrevoets,Ype Elgersma,Maarten H. Lequin	48
10	Health-Related Quality of Life in Children with Neurofibromatosis Type 1: Contribution of Demographic Factors, Disease-Related Factors, and Behavior 2008 ·The Journal of Pediatrics ·Lianne C. Krab,Rianne Oostenbrink,Arja de Goede-Bolder,Femke K. Aarsen,Ype Elgersma,Henriëtte A. Moll	66
11	Impact of Neurofibromatosis Type 1 on School Performance 2008 ·Journal of Child Neurology ·Lianne C. Krab,Femke K. Aarsen,Arja de Goede-Bolder,Coriene E. Catsman‐Berrevoets,Willem F. Arts,Henriëtte A. Moll,Ype Elgersma	95
12	Parental Reports of Health-Related Quality Of Life in Young Children with Neurofibromatosis Type 1: Influence of Condition Specific Determinants 2007 ·The Journal of Pediatrics ·Rianne Oostenbrink,(unknown),Arja de Goede-Bolder,Jeanne M. Landgraf,Hein Raat,Henriëtte A. Moll	35
13	Social participation of patients with hemophilia in the Netherlands 2007 ·Blood ·Iris Plug,Marjolein Peters,Eveline P. Mauser‐Bunschoten,Arja de Goede-Bolder,L. Heijnen,Cees Smit,José Willemse,Frits R. Rosendaal,Johanna G. van der Bom	67
14	Mortality and causes of death in patients with hemophilia, 1992–2001: a prospective cohort study 2006 ·Journal of Thrombosis and Haemostasis ·Iris Plug,Johanna G. van der Bom,Marjolein Peters,E. P. Mauser‐Bunschoten,Arja de Goede-Bolder,L. Heijnen,Cees Smit,J. Willemse,F.R. Rosendaal	224
15	In vivo recovery and safety of human factor VIII product AAFACT^® in patients with haemophilia A 2003 ·Haemophilia ·Paula J.M. Vossebeld,(unknown),H. Marijke van den Berg,Frank W.G. Leebeek,Arja de Goede-Bolder,I.R.O. Nováková,W.B.J. Gerrits,Marjolein Peters,Maria M.W. Koopman,(unknown),Harry Hiemstra,P. J. Grob,Paul Strengers	5
16	Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors 2002 ·Haemophilia ·E. P. Mauser‐Bunschoten,(unknown),Arja de Goede-Bolder,Frank W.G. Leebeek,J. van der Meer,Gijs Kooij,(unknown),(unknown)	25
17	Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis team of Sophia Children's Hospital. 1998 ·Journal of Medical Genetics ·Marjon H. Cnossen,Karel G.M. Moons,Marcel P.J. Garssen,(unknown),Arja de Goede-Bolder,Martinus F. Niermeijer,D. E. Grobbee	29
18	A prospective 10 year follow up study of patients with neurofibromatosis type 1 1998 ·Archives of Disease in Childhood ·Marjon H. Cnossen,Arja de Goede-Bolder,(unknown),(unknown),A. P. Oranje,Hans Stroink,Huibert J. Simonsz,A.M.W. van den Ouweland,Dicky Halley,Martinus F. Niermeijer	82
19	Deletions spanning the neurofibromatosis type 1 gene: Implications for genotype-phenotype correlations in neurofibromatosis type 1? 1997 ·Human Mutation ·Marjon H. Cnossen,(unknown),Martijn H. Breuning,Christi J. van Asperen,(unknown),Ans T. van der Ploeg,Arja de Goede-Bolder,(unknown),D. J. J. Halley,Martinus F. Niermeijer	92
20	Diagnostic delay in neurofibromatosis type 1 1997 ·European Journal of Pediatrics ·Marjon H. Cnossen,Frank J. Smit,Arja de Goede-Bolder,Petra G. Frets,H.J. Duivenvoorden,Martinus F. Niermeijer	20

About Arja de Goede-Bolder

Arja de Goede-Bolder is a scholar working on Hematology, Neurology and Speech and Hearing, having authored 22 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neurofibromatosis and Schwannoma Cases (9 papers), Platelet Disorders and Treatments (6 papers) and Hemophilia Treatment and Research (5 papers). The work is most often cited by research in Hematology (583 citations), Neurology (482 citations) and Genetics (161 citations). Arja de Goede-Bolder has collaborated with scholars based in Netherlands, United States and Canada. Frequent co-authors include Johanna G. van der Bom, Henriëtte A. Moll, E. P. Mauser‐Bunschoten, Lianne C. Krab, Ype Elgersma, Marjolein Peters, Cees Smit, Marjon H. Cnossen, Iris Plug and L. Heijnen. Their work appears in journals such as Blood, PEDIATRICS and The Journal of Pediatrics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact